Article

Murine models for triple-negative breast cancer with differential responsiveness to immunotherapy

2025-09-21

Abstract excerpt

<h4>ABSTRACT</h4> Breast cancer is the most common cancer diagnosis in women. Clinical studies with triple-negative breast cancer (TNBC) are encouraging for immunotherapy combined with chemotherapy (anti-PD-1 with paclitaxel and/or carboplatin). However, additional clinical advances may be pursued more rapidly with assistance from preclinical TNBC models including syngeneic mammary tumor cell lines. Here, we repo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 676e4520-7b84-5445-8ae7-a7010ac18c88
DOI: 10.1101/2025.09.18.677171

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Murine models for triple-negative breast cancer with differential responsiveness to immunotherapyDOI 10.1101/2025.09.18.677171Read

Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceSemantic proximity Read

Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast CancersSemantic proximity Read

Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceSemantic proximity Read

Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor ModelSemantic proximity Read

From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapiesSemantic proximity Read

A Novel Mouse Model that Recapitulates the Heterogeneity of Human Triple Negative Breast CancerSemantic proximity Read

Advances in immunotherapy for triple-negative breast cancerSemantic proximity Read

Type-I interferon signaling is essential for robust metronomic chemo-immunogenic tumor regression in murine triple-negative breast cancerSemantic proximity Read

Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterpartsSemantic proximity Read

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancerSemantic proximity Read

Temporal Changes in Immune Responses within the Tumor Microenvironment in the 4T1.2-HER2 Mammary Tumor ModelSemantic proximity Read

Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumorsSemantic proximity Read